Tesamorelin, a synthetic peptide molecule contains 44 amino acids, similar to hGRF derivative. The chemical contains trans-3-Hexenoic acid group, and being commercialized as Egrifta. Initially, Tesamorelin was developed by a Canadian firm called Theratechnologies, Inc. Facilitates release of growth hormone via the pituitary gland and cause catabolism of excessive adipose abdominal fat. Clinical studies reported that Tesamorelin reduce lipodystrophy in…
Domestic